GGrantIndex
Sort

326,823 grants matching clinical trial

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,083,076
David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2010 · RR

Cincinnati Comprehensive Sickle Cell Center

$2,083,011
Children'S Hospital Med Ctr (Cincinnati) · U54 · FY2005 · HL

Targeting Cancer Through Modifications and Metabolism

$2,082,969
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Normal and Neoplastic Growth in the Brain

$2,082,888
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2015 · CA

The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer

$2,082,690
Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA

Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)

$2,082,659
Amita Gupta · Johns Hopkins University · UM1 · FY2022 · AI

Characterization of the Osteosarcoma Genome

$2,082,634
Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

TRIP: Targeted Gene Therapy for the Treatment of Heart Failure

$2,082,299
Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P50 · FY2014 · HL

Protective immunity following dengue virus natural infections and vaccination

$2,082,273
Eva Harris · University Of California Berkeley · P01 · FY2019 · AI

SPORE in Lymphoma

$2,082,168
Johns Hopkins University · P50 · FY2002 · CA

HIV VACCINE TRIAL CLINICAL UNIT

$2,081,737
Harvard University (Medical School) · U01 · FY2003 · AI

University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection

$2,081,657
Anna Wald · University Of Washington · U19 · FY2021 · AI

(HVTN) HIV VACCINE TRIAL UNITS

$2,081,637
Johns Hopkins University · U01 · FY2003 · AI

Genetic Approaches to Cancer Immunotherapy

$2,081,408
Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA

HEAL Sickle Cell and CDE Supplement

$2,081,355
Jonathan Michael Dean · University Of Utah · U24 · FY2023 · TR

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,081,161
David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2008 · RR

Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence

$2,080,746
Audra L Stinchcomb · Alltranz, Inc. · RC2 · FY2009 · DA

New Approaches To Active Immunoprophylaxis

$2,080,655
Robert H. Purcell · Niaid Extramural Activities · Z01 · FY2007 · AI

COMPREHENSIVE SICKLE CELL CENTER OF MANHATTAN

$2,080,603
Columbia University Health Sciences · P60 · FY2002 · HL

Off-the-Shelf Immune Effector Cells for Hematological Malignancies

$2,080,518
John E Wagner · University Of Minnesota · P01 · FY2025 · CA

Rapid Multipathogen Detection for POCT and National Diaster Readiness

$2,080,348
Gerald Joseph Kost · University Of California At Davis · U54 · FY2007 · EB

Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative

$2,080,338
Helen S Mayberg · Emory University · U19 · FY2012 · MH

Mechanisms and Markers of Prostate Cancer Metastases

$2,080,291
Robert Vessella · University Of Washington · P01 · FY2012 · CA

A selective angiogenesis blocker to treat retinopathy of prematurity

$2,080,258
Wei Li · Baylor College Of Medicine · R24 · FY2022 · EY

Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials

$2,080,252
Terry Goldberg · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2021 · AG